InsidersTradesSigma
Panacea Life Sciences Holdings, INC.: insider trades · United States · SEC (Form 4)
SEC:panacea-life-sciences-holdings-inc-e412f1US·SEC (Form 4)Mcap 1M€Healthcare
Discover the full insider trade history of Panacea Life Sciences Holdings, INC., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Panacea Life Sciences Holdings, INC. has published 1 public disclosures. Market capitalisation: €594k. The latest transaction was disclosed on 6 April 2022 — Acquisition. Among the most active insiders: Buttorff Leslie. All data is free.
1
Insider Decl.
0
Thresholds
€5,011
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2023 · cache
0.03 €
Analyst consensus
Income statement
Revenue2.4 M€
Gross profit1.1 M€47% margin
Net income−8.0 M€-277.5% margin
Valuation
Beta2.63
Balance sheet & cash
Market cap594 k€
Total debt21.6 M€
Free Cash Flow−1.6 M€
Profitability & ownership
ROA-18.5%
% insiders47.7%
% institutions0.0%
Last declaration on 6 April 2022
Declarations1 total
Executives▲Purchase◆Signal · 50SEC
€5,01111,000 shares@ €0.45550.84% mcap100.0% of flow
Common Stock
SEC:0001493152-22-009276:0·
Ideal exit: 30 Dec 2022 (T+270)
1 of 1 declaration